Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIIOngoingD-1471-2022

Drug recall · September 7, 2022

Timolol Maleate Ophthalmic Solution recall

Why: Failed Impurities/Degradation Specifications: Identification of an unknown impurity at the 12-month stability point.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Timolol Maleate Ophthalmic Solution, USP, 0.5%, 5 x 0.3 mL Single-Dose Vials, Rx Only, Sterile, Manufactured for: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-189-24

Lots / codes

Lot #: 9N72, EXP 09/30/2022

Quantity
5,226 Cartons (60 vials/carton)
Company
Akorn, Inc, Gurnee, IL
Distribution
Distributed Nationwide in the USA
Initiated
August 8, 2022 · Voluntary: Firm initiated
Classified
August 29, 2022
Reported
September 7, 2022
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Timolol

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.